soul trial oral semaglutide cardiovascular outcomes results 2025 nejm and in Patients with Type 2 Diabetes Cardiovascular outcomes of semaglutide and

Say farewell to injections and embrace an effortless approach

Researchers say GLP-1 weight loss medications such as Ozempic, Rybelsus, and Wegovy are effective for long-term weight loss as well as improving heart health

It mimics naturally occurring hormone action in glucose regulation

Over the past year, Ive seen a growing number of patients achieving remarkable weight-loss success with GLP-1 medications

No, Ozempic (semaglutide) is not FDA-approved for use in children or adolescents under 18 years of age for any indication

This lowest starter strength allows your digestive tract to build seamless biological tolerance while minimizing initial side effects